Focus: Adienne Pharma and Biotech is a specialty pharmaceutical company focused on biologics and biosimilars with a marketed portfolio spanning oncology, infectious diseases, and gastroenterology. The company operates from Italy with a small, focused employee base and minimal disclosed R&D pipeline activity.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Adienne Pharma and Biotech to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Adienne Pharma and Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Adienne Pharma and Biotech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Core revenue driver at peak sales; patent protection extends to August 2035 before generic erosion accelerates.
Alkylating agent with durable patent protection (LOE 2037); Part D spending data unavailable, suggesting smaller revenue contributor.
Minimal revenue ($151K); currently experiencing supply shortages due to limited availability, signaling manufacturing or competitive pressures.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo